Surgical Management of Secondary Hyperparathyroidism in Uremia
- 1 June 1999
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 317 (6) , 390-7
- https://doi.org/10.1097/00000441-199906000-00007
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Clonal Analysis of Nodular Parathyroid Hyperplasia in Renal HyperparathyroidismWorld Journal of Surgery, 1996
- Secondary hyperparathyroidism in renal failure: The trade-off hypothesis revisitedAmerican Journal of Kidney Diseases, 1995
- 1-Alpha-Hydroxyvitamin D3 Derivatives in the Treatment of Renal Bone Diseases: Justification and Optimal Modalities of AdministrationNephron, 1995
- Parathyroidectomy for patients with renal hyperparathyroidism refractory to calcitriol pulse therapyJournal of Bone and Mineral Metabolism, 1994
- Recurrent renal hyperparathyroidism and DNA analysis of autografted parathyroid tissueWorld Journal of Surgery, 1992
- The ‘Oral 1,25-Dihydroxyvitamin D3 Pulse Therapy’ in Hemodialysis Patients with Severe Secondary HyperparathyroidismNephron, 1991
- Intravenous Calcitriol in the Treatment of Refractory Osteitis Fibrosa of Chronic Renal FailureNew England Journal of Medicine, 1989
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.Journal of Clinical Investigation, 1989
- Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.Journal of Clinical Investigation, 1984
- Parathyroid Pathology in Hyperparathyroidism Secondary to Chronic Renal FailureScandinavian Journal of Urology and Nephrology, 1984